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research article 
Drug Resistance in Malaria: A Peruvian Research Experience 
—Ryan Haley (Edited by Mandy Chesley–Park) 
To begin, I’ll start with the descent.  As my Boeing 747 
flew over the Peruvian rainforest, I looked out the 
window and stared down at strings of lights that 
appeared to be either convoys of boats or small cities 
along the Amazon River.  Upon landing in Lima at 2 
a.m., I quickly got my bags, spotted the taxi driver 
holding a sign with my name, and made my way 
through the screaming crowd.  We raced through the 
city, the driver dodging potholes and calmly talking to 
me in Spanish while I tightly clutched my seat. At 4 a.m., 
after traveling for over twenty–four hours, I finally 
arrived at my apartment with two hours to sleep before 
I had to get ready for work.  I opened my journal, noted 
the date and time, and wrote “70 days left.” My arrival 
officially marked the first day of my summer 2007 
research experience working for the United States Navy as a medical scientist studying malaria.  Previously, I 
had known the disease only through textbooks and movies, but a summer in Peru would certainly change that. 
An Introduction to the Problem 
Malaria is caused by several different species of bacteria, but Plasmodium falciparum is the name of the 
single–celled parasite most widely known to cause this infectious disease (1).  The parasite is transmitted by 
mosquitoes to humans, where it infects red blood cells and multiplies within them.  These cells eventually 
rupture releasing more parasites that can restart the process in the human body or enter another mosquito 
and in turn spread infection.  The parasite lodges itself in the host’s liver, meaning that those who survive an 
initial infection may later be reinfected when the parasite becomes active again (2). 
Malaria strikes over 500 million people annually, causing fatigue, high fever, severe chills, sweats, nausea, and 
vomiting, which can result in up to 2.7 million deaths each year, mostly in children (2).  Several anti–malarial 
drugs, including quinine, have been developed in efforts to prevent reinfection by inhibiting the parasite’s 
ability to draw sustenance from human blood cells (1,3).  However, just as the overuse of anti–bacterial drugs 
has created drug resistant strains of bacteria, the overuse of anti–malarial drugs can create drug resistant 
strains of malaria.  In parts of the world where overuse of a single drug is prevalent, such as the jungles of  
The author at the US laboratory outpost in the Amazon. 
Southeast Asia, central Africa, and northern South America, strains of bacteria resistant to this drug have been 
discovered (4,5).   As a result, doctors are finding themselves unable to treat a disease that was once 
treatable. 
My reason for traveling to Peru was to investigate this drug resistance at the genetic level.  I went with the 
knowledge that the parasite’s resistance to several anti–malarial drugs has been shown to correlate with the 
number of copies of the pfmdr1 (Plasmodium falciparum multiple drug resistance 1) gene present (6).  This 
gene is found within both resistant and non–resistant strains of the bacteria Plasmodim falciparum, but its 
mutation is what gives the parasite drug resistance (6).  When the pfmdr1 gene mutates, the protein the gene 
codes for also changes.  The modified protein makes the organism resistant to a large number of anti–malarial 
drugs.  Having more than one copy of this gene further enhances the parasite’s drug resistance by increasing 
the rate of protein production.  This is similar to having multiple workers help build a house: just as a house is 
built faster with more manpower, drug resistance of the malaria parasite builds with greater numbers of the 
mutated pfmdr1 gene. The goal of my study was to learn if the malaria strains circulating in the Peruvian 
Amazon carried multiple copies of this gene, or if other factors were responsible for drug resistance in this 
region. 
To answer my research question I spent the majority of my 
time at the main US military laboratory in Lima. Here I 
separated out DNA from infected patients’ blood samples 
and performed real–time polymerase chain reaction (PCR), a 
process in which millions of copies of a small section of the 
pfmdr1 gene are made from the parasite’s DNA using two 
tiny strands of DNA called primers.  This process was 
repeated, allowing the primers to attach to both the newly 
created DNA and the original parasite’s DNA. I then 
compared the patients’ samples to the lab–grown samples 
and determined how many copies of pfmdr1 were present in 
the parasite infecting each patient. 
Fieldwork in the Peruvian Amazon 
After six weeks of lab work in Lima, my mentor, Lt. Dr. Bacon, asked me to travel with him into the Amazon to 
get an overview of his malaria project. After spending the first day with Dr. Bacon and other research 
scientists, I would then be left to work alongside a physician for eleven days in the rainforest.  I was excited to 
witness firsthand the importance of my laboratory work. 
As we landed in Iquitos, a small city located on the Amazon River, an unbearable wave of heat washed over 
me, and I instantly started to sweat in my slacks and long–sleeved dress shirt.  The airport consisted of a small 
building and a slab of pavement seemingly dropped in the middle of the rainforest.  Our driver took us to the 
military base, zooming through narrow streets filled with open air markets; houses painted in vibrant whites, 
reds, blues, and yellows; and thousands of people wandering in loose–fitting clothes and flip–flops. I received 
a tour of the laboratory facilities and then spent the rest of the day traveling to one of the three malaria field 
sites from where my lab samples had come. We traveled up river on a long, slender single–engine boat to the 
village of Padre Cocha. On a hill stood a small cement health clinic occupied by a Peruvian infectious disease 
physician and a laboratory technician.  The building’s paint was chipping and both the door and windows were 
missing.  There were no malaria patients that day; a slow day, but it was the dry season. 
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The next day Dr. Bacon and the other scientists left 
Iquitos.  I met with the Peruvian physician, a thin man 
named Soloman, and we traveled to a different site. This 
tiny village was made up of wooden homes with thatched 
roofs of palm leaves. The clinic was similar to the one in 
Padre Cocha, except that this day we had business.  
Several little boys sat on a wooden bench outside the 
clinic; one, wearing a pair of flip–flops, shorts, and a 
Mickey Mouse sweat shirt, was visibly shaking and 
sweating.  He crossed his arms tightly, huddling to stay 
warm despite the intense heat of the jungle. 
“That one looks like a malaria patient for the study,” 
Soloman told me.  After examining the boy and taking a 
blood sample, we looked under the microscope and quickly recognized infected blood cells.  The boy would 
make a good patient for our study.  This was just one of many malaria patients I saw in my short visit to 
Iquitos; returning to Lima, I knew that their blood samples wouldn’t be far behind me. 
The “Big Picture” 
Back in Lima, I began to understand the larger picture and purpose of my work.  I spent the remainder of my 
days in Peru analyzing hundreds of new samples from individuals infected with malaria.  I tested each sample 
three times to ensure the number of pfmdr1 copies I was observing was correct.  In all of these samples I did 
not find a single infected patient whose sample possessed two or more pfmdr1 genes.  These results showed 
that increased anti–malarial drug resistance in Peru is not simply due to the presence of multiple copies of the 
pfmdr1 gene; rather, there is more to it. 
Although this was not the answer I had anticipated, because 
of my research there is now one less possible reason for 
increased  anti–malarial drug resistance in Peru, making it 
easier for scientists to identify the true reason.  My data 
showed that this type of testing could be used in other 
countries whose populations are infected with malaria to 
develop more appropriate methods of treatment and slow 
down the spread of drug–resistant strains. While malaria 
may not be a large problem here in the United States, it is 
important to know that millions of people suffer from this 
disease. Learning how drug resistance develops will help 
scientists continue to effectively treat malaria and other 
diseases world wide 
On my last day, after saying my goodbyes and returning from work, I packed my belongings to leave the 
country I had come to call home.  Although I would be returning to the United States, the important work I did 
in Peru would continue on in other researchers’ hands. One last race through the city, a good conversation in 
Spanish with the taxi driver, and I arrived at the same airport where my summer research experience had 
begun. 
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Later, as I went through US customs in Georgia, a tall, thin woman in a red airport suit looked over my 
passport carefully.  She raised her head, smiled, and in beautiful English said, “Good morning sir, you’ve been 
gone a long time.  Welcome home.”  I was home.  So much had happened to me; I had done and seen things I 
never could have imagined.  I learned the answer to my research question, and learned a lot about myself as 
well.  My summer in Peru was the most difficult thing I have ever done in almost every way, but it was by far 
the most rewarding. 
I would like to thank the Hamel Center for Undergraduate Research for their financial support of my study 
through a Summer Undergraduate Research Fellowship (SURF) Abroad.  I would also like to thank Dr. Louis Tisa 
of the University of New Hampshire Department of Microbiology for his expert help in writing the grant 
proposal, the final report, and overall as my sponsor.  Finally, I would like to thank Lt. Dr. David Bacon for 
hosting me both as a researcher and as a visiting scientist.  His unique style of mentoring has, for me, been 
incredibly influential in my discovery of the scientific process. 
References 
1. Baird KJ.  Chloroquine resistance in plasmodium vivax.  Antimicrob Agents Chemother. 2004 Nov; 
48(11): p4075-4083. 
2. Leder K, Weller PF. Epidemiology, pathogenesis, clinical features, and diagnosis of malaria. UpToDate 
[online database]. 2006 Aug [Accessed Dec 20, 2006]; c2006: p 15. 
3. Mockenhaupt FP, et all. Markers of sulfadoxine–pyrimethamine resistant falciparum malaria in 
placenta and circulation of pregnant women. Antimicrob Agents Chemother. 2006 Nov; 10: p13. 
4. Pinedo–Cancino V, et all.  Limited diversity of anopheles darlingi in the Peruvian Amazon region of 
Iquitos. Am J Trop Med Hyg. 2006 Aug; 75(2):238–245. 
5. Ernst KC, et all. Malaria hotspot areas in highland Kenya site are consistent in epidemic and non–
epidemic years and are associated with ecological factors. Malaria J. 2006 Sep; 5(78): p10. 
6. Veiga MI, et all. Multiplex pcr–rflp methods of pfcrt, pfmdr1 and pfdhfr mutations in plasmodium 
falciparum. Mol Cel Probs. 2006 Feb; 20:100–104. 
 




Looking back on his Peruvian experience, Ryan Haley describes it as both a painful and rewarding experience. 
He quickly adds, “I would do it again in a heartbeat.” Ryan is finishing his last year as a biochemistry major 
and will be graduating in May 2008. Although he originally envisioned himself as a scientific researcher, 
following his experience in Peru, Ryan realized the demand there was for physicians not only in the United 
States but throughout the world. Now Ryan is feverishly applying to medical schools. He is glad he received 
“real world” experience during his SURF Abroad project; he also learned that travel and research demand 




For Dr. Louis S. Tisa, mentoring is synonymous to teaching; “I try to help my students reach their full potential 
in any of their endeavors,” he explains. When Ryan approached Dr. Tisa with a SURF proposal to study 
malaria in Peru, Tisa was very supportive. Having worked with Ryan over the last year and half, Tisa knew that 
Ryan’s work ethic would benefit both his experience and his on–site research. When asked if he too has 
benefited from Ryan’s experience, he quickly responds, “What I gained from this experience was the 
satisfaction that I helped Ryan broaden his life’s experience by living in another country that had a totally 
different culture.” Furthermore, he reports that the molecular techniques Ryan learned in Peru have aided him 
in his classroom lab research. Tisa is an associate professor of microbiology and genetics at the University of 
New Hampshire. He takes pride in his students’ progress and is proud of his work as a faculty mentor for the 
Research and Engineering Apprentice Program, in which he mentors socially disadvantaged high school 
students by encouraging them to pursue careers in math, science, and technology through hands–on experience. 
